Recommended Reading From Around The Web
Talk of booster shots is now being given a front stage as millions of people become eligible for the additional dose of the COVID-19 vaccine. Reflecting on how the pandemic gave a boost (no pun intended) to one of the stocks that we surfed, needle manufacturing company Retractable Technologies, Inc. (AMEX:RVP), it begs the question – what lies in store for companies that were able to capitalize on the medical demand for things such as needles, PPE and something as speculative as vaccine R&D? While it’s possible you’ve read up on the subject matter, a small piece by Bloomberg defines possible reasons why boosters will be in demand for the foreseeable future:
“Some of us need boosters for two reasons. The first is that the protection against mild and moderate illness provided by the initial vaccination appears to wane over time, especially among older individuals,” says Jessica Justman, an epidemiologist at Columbia University.
“The second reason is that the delta variant is more infectious. This means everyone, even vaccinated people, is more likely to get exposed to an infectious dose of the virus and have it challenge their immune system. The booster helps your immune system mount an effective response.”
While the market has likely already rooted out the players that were obviously taking advantage of investors’ appetites to preemptively invest in lighting-in-a-bottle COVID-related stocks, we still have to keep our eye out for legitimate opportunities that might present themselves should the environment evolve.
Read the Bloomberg article here.